Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, June 6, 2013

SPS3: Systolic BP <130 beneficial in lacunar stroke

Check with your hospital and see when they plan to implement. You do want them to save neurons, don't you?
http://www.theheart.org/article/1547245.do?utm_medium=email&utm_source=20130606_heartwire&utm_campaign=newsletter
Lowering systolic blood pressure to <130 mm Hg in patients with recent lacunar stroke is likely to be beneficial, results from the Secondary Prevention of Small Subcortical Strokes (SPS3) trial show [1].
Although the primary end point was not quite significant, it did suggest a reduction in stroke in the lower-BP group. In addition, the secondary end point of hemorrhagic stroke was significantly reduced.
"Our results are consistent with previous trials of blood-pressure lowering after stroke and support a treatment target of less than 130 mm Hg systolic for most patients with recent lacunar stroke," commented lead investigator Dr Oscar R Benavente (University of British Columbia, Vancouver).
Their findings were presented here at the European Stroke Conference 2013 on May 29, 2013 and published simultaneously online in the Lancet. Preliminary results of the blood-pressure-lowering arm of SPS3 were presented earlier this year at the International Stroke Conference 2013 in February and reported at that time.
A second arm of the trial, published previously in the New England Journal of Medicine, looked at antiplatelet regimens and showed no benefit from combined aspirin and clopidogrel over aspirin alone in this same population
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)